Skip to main content

Table 3 Summary of perioperative characteristics

From: Safety and efficacy of Cox‐Maze procedure for atrial fibrillation during mitral valve surgery: a meta-analysis of randomized controlled trials

First author

CBP time (min)

Cross-clamp time (min)

MVP (%)

MVR (%)

Other surgeries

Mortality at 30 d

Mortality at 12mo

Thromboembolic at12mo

Maze + MVS

MVS

Maze + MVS

MVS

Maze + MVS

MVS

Maze + MVS

MVS

Maze + MVS

MVS

Maze + MVS

MVS

Maze + MVS

MVS

Maze + MVS

MVS

Deneke, T

188.0

127.0

103.0

85.0

0.0

0.0

100.0

100.0

0.0

0.0

13.0

0.0

73.0

93.0

0.0

0.0

Akpinar, B

140.5 ± 34.3

128.3 ± 28.3

88.5 ± 13.4

78.9 ± 9.4

36.0

38.0

64.0

62.0

27.3

20.6

3.0

2.9

3.0

2.9

0.0

6.0

Jessurun, E. R

155.0 ± 27.0

97.0 ± 27.0

90.0 ± 24.0

60.0 ± 18.0

40.0

40.0

60.0

60.0

24.0

30.0

0.0

0.0

0.0

0.0

0.0

0.0

de Lima, G. G

115.3 ± 25.0

68.3 ± 22.0

NR

49.1 ± 19.0

80.0

60.0

20.0

40.0

0.0

0.0

0.0

0.0

10.0

0.0

0.0

10.0

Abreu Filho, C. A

107.2 ± 21.1

78.2 ± 24.4

67.5 ± 13.5

47.1 ± 15.8

30.9

3.5

69.1

96.5

26.1

28.5

2.3

0.0

4.9

7.2

0.0

0.0

Chevalier, P

NR

NR

93 ± 32

74 ± 19

19.0

59.9

45.5

80.9

19.0

40.9

4.8

0.0

4.8

0.0

4.8

13.6

von Oppell, U. O

176 ± 42

160 ± 55

143 ± 35

119 ± 44

66.7

60.0

33.3

40.0

54.1

64.0

NR

NR

0.0

8.0

4.0

0.0

Gillinov, A. M

147.8 ± 63.3

132.5 ± 51.0

102.9 ± 41.5

95.9 ± 36.3

59.4

51.6

40.6

48.4

37.6

38.1

NR

NR

6.8

8.7

3.0

1.6

Wang, H

164.82 ± 30.57

107.03 ± 18.96

88.06 ± 13.46

54.20 ± 8.49

0.0

0.0

100.0

100.0

33.8

32.3

1.5

1.5

6.2

13.9

1.5

4.6